__NUXT_JSONP__("/drugs/Minretumomab", (function(a,b){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[],id:a,nciThesaurus:{casRegistry:"195189-17-4",chebiId:b,chemicalFormula:b,definition:"A second-generation murine monoclonal antibody based on the antibody B72.3 that is directed against tumor-associated glycoprotein 72 (TAG72).  TAG72 is expressed by gastric, breast, pancreatic, colorectal, and ovarian carcinoma cells.",fdaUniiCode:"235435CH6L",identifier:"C2567",preferredName:a,semanticType:"Amino Acid, Peptide, or Protein",subclassOf:["C129822","C20401"],synonyms:["Antibody CC49, Monoclonal","CC-49","CC-49 Monoclonal Antibody","MAb CC49","MINRETUMOMAB","MOAB CC-49\u002FTAG72 (DW)",a,"MoAb CC49","Monoclonal Antibody CC-49","Monoclonal Antibody CC49"]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FMinretumomab",extension:".json",createdAt:"2021-10-30T13:37:48.533Z",updatedAt:"2021-10-30T13:37:48.543Z"}}],fetch:{},mutations:void 0}}("Minretumomab","")));